Newly-released Hospital Surgical Disinfectant market analysis report by Future Market Insights shows that global sales of the Hospital Surgical Disinfectant market in 2021 were held at US$ 370.3 million. With 7.3%, the projected market growth from 2022 to 2032 is expected to be significantly higher than the historical growth. The absolute dollar opportunity for the Hospital Surgical Disinfectant market is projected at US$ 401.5 million.
| Attribute | Details |
|---|---|
| Global Hospital Surgical Disinfectant Market (2022) | USD 395.1 million |
| Global Hospital Surgical Disinfectant Market (2032) | USD 796.6 million |
| Global Hospital Surgical Disinfectant Market CAGR (2022 to 2032) | 7.3% |
| The USA Hospital Surgical Disinfectant Market (2022) | USD 117.3 million |
| Key Companies Profiled |
3M; Ecolab; Becton, Dickinson and Company (BD); Sage Products LLC; B. Braun Melsungen AG; Johnson & Johnson; Kimberly-Clark Corporation; Cardinal Health; The Clorox Company; Schulke & Mayr GmbH |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Hospital Surgical Disinfectant market research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Hospital Surgical Disinfectant market increased at around 6.3% CAGR, wherein, North America held a significant share in the global market.
Healthcare-associated infections (HAI) are a serious issue for both patients and healthcare staff worldwide. With an increase in the number of hospitalizations and HAIs globally, the demand for surgical tool disinfection is increasing to reduce the risk of microbial contamination. According to WHO, hundreds of millions of patients worldwide get HCAIs each year. In rich nations, 7 out of every 100 hospitalized patients have at least one HAI, whereas 10 in underdeveloped countries have at least one HAI. Owing to this, the Hospital Surgical Disinfectant market is projected to grow at a CAGR of 7.3% over the coming 10 years.
According to the Healthcare Cost and Utilization Project (HCUP), approximately 9 million operations were done in ambulatory care settings in the United States in 2020. In the event of operations, one of the most important needs in healthcare facilities is the use of surgical disinfection solutions. These products are more typically used in hospitals and other medical settings to lower the risk of infection during surgery and other operations because they prevent or limit the development of germs on the skin. As a result, such occurrences are projected to boost the market throughout the forecast period.
Surgical and diagnostic procedures may be required, which may require medical consumables Surgical Disinfectant. Hospitalization rates are predicted to rise as the frequency of chronic illnesses such as cardiovascular disease, cancer, diabetes, and other autoimmune disorders rises. The adoption of unhealthy and sedentary lifestyles, as well as antibiotic resistance, are the key factors to the increased prevalence of chronic diseases. According to the National Center for Health Statistics, an estimated 157 million Americans suffer from chronic sickness, with 81 million suffering from several conditions, as of 2018. Because of the rising frequency of chronic diseases, hospital admissions have skyrocketed. Surgical disinfectants are needed in hospitals to keep humans and non-living materials germ-free. Such factors are predicted to drive demand for hospital surgical disinfectants throughout the forecast period.
Principal Consultant
Hospital Surgical Disinfectant market revenue is estimated to expand at the fastest rate in APAC from 2022 to 2032, with around 8.9% and 9.9% projected growth rates in China and Japan, respectively. Some of the significant corporations, that have manufacturing units in all major APAC locations, have begun to extend their production units to other APAC sites in order to boost the speed of distribution. While this suggests a shift in global geographical diversification, it represents a substantial potential for the market.
Hospital-acquired illnesses and advancements in healthcare infrastructure contribute to the increased use of hospital surgical disinfectants. Furthermore, regulatory regulations aimed at providing safe and high-quality healthcare services are expected to drive market expansion throughout the projection period.
For example, the Chinese regulatory authority, the National Medical Products Administration, declared that it will expedite the registration of medical disinfectants that fulfill applicable requirements in the United States, Japan, and the European Union. As a result, these factors are projected to drive market expansion throughout the forecast period. Furthermore, rising illnesses and surgeries in the region are likely to drive market expansion even further. The area's highest number of procedures and surgeries is also propelling the industry in this region. Medical tourism is popular in Asian nations such as China, India, and Thailand.
The USA dominated the North America Hospital Surgical Disinfectant market and is poised to reach USD$ 220.3 million by 2032. The favorable factors in USA market growth are reimbursement and technological advancement facilities in the country. The growing number of hospital admission and the ease of medicare reimbursement policy favors the market growth.
In the United States, according to the American Hospital Association, there were 6,090 community hospitals, 208 Federal Government hospitals, and 625 nonfederal psychiatric hospitals. The number of admissions for chronic diseases has significantly increased, raising product demand and accelerating market expansion. The availability of strong transportation and easy access to healthcare facilities are two fundamental contributors to the market expansion.
According to the United States Department of Health and Human Services, 0.4% of the roughly 150 million Americans who get admitted to a hospital on any given day are contaminated by an HAI. The loss of health insurance is likely to cause more people to seek medical care, along with the number of snakebites, dengue fever, tuberculosis, malaria, and typhoid, as well as the anticipated increase in cases of COVID-19 in the USA, which are predicted to expand the market.
The market in the United Kingdom is projected to grow from US$ 17.7 million in 2022 to reach a valuation of US$ 41.1 million by 2032. From 2022 to 2032, the market is projected to garner an absolute dollar opportunity of US$ 23.4 million, growing at a CAGR of 8.9%.
The market in Japan is projected to reach a valuation of US$ 32.6 million by 2032, growing at a CAGR of 9.9% from 2022 to 2032. The market in Japan is likely to garner an absolute dollar opportunity of US$ 19.7 million from 2022 to 2032.
The market in South Korea is projected to reach a valuation of US$ 13.3 million by 2032, growing at a CAGR of 5.8%. The market in the country will witness an absolute dollar opportunity of US$ 5.8 million from 2022 to 2032.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market for hydrogen peroxide solutions is expected to grow at 5.8% CAGR during the forecast period. The rising demand for hydrogen peroxide-based solutions to be merged with other additives, such as iodine and alcohol, is stimulating market development. In addition, the demand for hydrogen peroxide has grown as a result of a rise in the demand for hand wash products, such as sanitizers, which are efficient against many germs.
To increase knowledge and use among patients of surgical disinfectants prior to and during surgical procedures, the CDC recommends that patients shower with a detergent containing hydrogen peroxide prior to undergoing treatment.
Corporations are expanding their corporate footprint in emerging areas through strategic alliances and agreements, as well as focusing on improving distribution networks. This is expected to boost the expansion of the high-level disinfection services market.
The key vendors in the global market are 3M, Ecolab, Becton, Dickinson and Company (BD), Sage Products LLC, B. Braun Melsungen AG, Johnson & Johnson, Kimberly-Clark Corporation, Cardinal Health, The Clorox Company, Schulke & Mayr GmbH, among others.
Some of the recent development in the Hospital Surgical Disinfectant market are:
The global market is worth more than US$ 395.1 million at present.
The value of the Hospital Surgical Disinfectant market is projected to increase at a CAGR of around 7.3% from 2022 to 2032.
The value of the Hospital Surgical Disinfectant market increased at a CAGR of around 6.3% from 2017 to 2021.
The top 5 countries driving demand for the market are the USA, China, The United Kingdom, Japan, and South Korea.
The value of the Hospital Surgical Disinfectant market is projected to increase at a CAGR of around 6.6% from 2022 to 2032 in North America.
The US market for Hospital Surgical disinfectants is projected to expand at a CAGR of around 6.5% during 2022 to 2032.
The major companies are 3M, Ecolab, Sage Products LLC, B. Braun Melsungen AG, and Kimberly-Clark Corporation.
1. Executive Summary | Hospital Surgical Disinfectant Market
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ million)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background and Foundation Data Points
4.1. Global Market (US$ million)
4.2. Market Opportunity Assessment (US$ million)
4.2.1. Total Available Market
4.2.2. Product Typeable Addressable Market
4.2.3. Product Typeable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Global Market Growth
4.5.3. Adoption Rate, by Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Market Demand Analysis 2017 to 2021 and Forecast, 2022 to 2032
6.1. Historical Market Analysis, 2017 to 2021
6.2. Current and Future Market Projections, 2022 to 2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Market Value Analysis 2017 to 2021 and Forecast, 2022 to 2032
7.1. Historical Market Value (US$ million) Analysis, 2017 to 2021
7.2. Current and Future Market Value (US$ million) Projections, 2022 to 2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ million) Analysis By Product Type, 2017 to 2021
8.3. Current and Future Market Size (US$ million) Analysis and Forecast By Product Type, 2022 to 2032
8.3.1. Chlorhexidine
8.3.2. Alcohols
8.3.3. Povidone-iodine
8.3.4. Octenidine
8.3.5. Hydrogen Peroxide
8.3.6. Other Product Types
8.4. Market Attractiveness Analysis By Product Type
9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
9.1. Introduction
9.2. Historical Market Size (US$ million) Analysis By Region, 2017 to 2021
9.3. Current Market Size (US$ million) & Analysis and Forecast By Region, 2022 to 2032
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia Pacific
9.3.5. Middle East and Africa (MEA)
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
10.1. Introduction
10.2. Pricing Analysis
10.3. Historical Market Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
10.4. Market Value (US$ million) & Forecast By Market Taxonomy, 2022 to 2032
10.4.1. By Country
10.4.1.1. The USA
10.4.1.2. Canada
10.4.2. By Product Type
10.5. Market Attractiveness Analysis
10.5.1. By Country
10.5.2. By Product Type
11. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
11.4. Market Value (US$ million) & Forecast By Market Taxonomy, 2022 to 2032
11.4.1. By Country
11.4.1.1. Brazil
11.4.1.2. Mexico
11.4.1.3. Rest of Latin America
11.4.2. By Product Type
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Product Type
12. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
12.4. Market Value (US$ million) & Forecast By Market Taxonomy, 2022 to 2032
12.4.1. By Country
12.4.1.1. Germany
12.4.1.2. France
12.4.1.3. The United Kingdom
12.4.1.4. Italy
12.4.1.5. Benelux
12.4.1.6. Nordic Countries
12.4.1.7. Rest of Europe
12.4.2. By Product Type
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product Type
13. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
13.4. Market Value (US$ million) & Forecast By Market Taxonomy, 2022 to 2032
13.4.1. By Country
13.4.1.1. China
13.4.1.2. Japan
13.4.1.3. South Korea
13.4.1.4. Rest of Asia Pacific
13.4.2. By Product Type
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product Type
14. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
14.4. Market Value (US$ million) & Forecast By Market Taxonomy, 2022 to 2032
14.4.1. By Country
14.4.1.1. GCC Countries
14.4.1.2. South Africa
14.4.1.3. Turkey
14.4.1.4. Rest of Middle East and Africa
14.4.2. By Product Type
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product Type
15. Key Countries Market Analysis 2017 to 2021 and Forecast 2022 to 2032
15.1. Introduction
15.1.1. Market Value Proportion Analysis, By Key Countries
15.1.2. Global Vs. Country Growth Comparison
15.2. US Market Analysis
15.2.1. Value Proportion Analysis by Market Taxonomy
15.2.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
15.2.2.1. By Product Type
15.3. Canada Market Analysis
15.3.1. Value Proportion Analysis by Market Taxonomy
15.3.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
15.3.2.1. By Product Type
15.4. Mexico Market Analysis
15.4.1. Value Proportion Analysis by Market Taxonomy
15.4.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
15.4.2.1. By Product Type
15.5. Brazil Market Analysis
15.5.1. Value Proportion Analysis by Market Taxonomy
15.5.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
15.5.2.1. By Product Type
15.6. Germany Market Analysis
15.6.1. Value Proportion Analysis by Market Taxonomy
15.6.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
15.6.2.1. By Product Type
15.7. France Market Analysis
15.7.1. Value Proportion Analysis by Market Taxonomy
15.7.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
15.7.2.1. By Product Type
15.8. Italy Market Analysis
15.8.1. Value Proportion Analysis by Market Taxonomy
15.8.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
15.8.2.1. By Product Type
15.9. BENELUX Market Analysis
15.9.1. Value Proportion Analysis by Market Taxonomy
15.9.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
15.9.2.1. By Product Type
15.10. UK Market Analysis
15.10.1. Value Proportion Analysis by Market Taxonomy
15.10.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
15.10.2.1. By Product Type
15.11. Nordic Countries Market Analysis
15.11.1. Value Proportion Analysis by Market Taxonomy
15.11.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
15.11.2.1. By Product Type
15.12. China Market Analysis
15.12.1. Value Proportion Analysis by Market Taxonomy
15.12.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
15.12.2.1. By Product Type
15.13. Japan Market Analysis
15.13.1. Value Proportion Analysis by Market Taxonomy
15.13.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
15.13.2.1. By Product Type
15.14. South Korea Market Analysis
15.14.1. Value Proportion Analysis by Market Taxonomy
15.14.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
15.14.2.1. By Product Type
15.15. GCC Countries Market Analysis
15.15.1. Value Proportion Analysis by Market Taxonomy
15.15.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
15.15.2.1. By Product Type
15.16. South Africa Market Analysis
15.16.1. Value Proportion Analysis by Market Taxonomy
15.16.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
15.16.2.1. By Product Type
15.17. Turkey Market Analysis
15.17.1. Value Proportion Analysis by Market Taxonomy
15.17.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
15.17.2.1. By Product Type
15.17.3. Competition Landscape and Player Concentration in the Country
16. Market Structure Analysis
16.1. Market Analysis by Tier of Companies
16.2. Market Concentration
16.3. Market Share Analysis of Top Players
16.4. Market Presence Analysis
16.4.1. By Regional footprint of Players
16.4.2. Product footprint by Players
17. Competition Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Competition Deep Dive
17.3.1. 3M
17.3.1.1. Overview
17.3.1.2. Product Portfolio
17.3.1.3. Sales Footprint
17.3.1.4. Strategy Overview
17.3.2. ECOLAB
17.3.2.1. Overview
17.3.2.2. Product Portfolio
17.3.2.3. Sales Footprint
17.3.2.4. Strategy Overview
17.3.3. BD
17.3.3.1. Overview
17.3.3.2. Product Portfolio
17.3.3.3. Sales Footprint
17.3.3.4. Strategy Overview
17.3.4. SAGE PRODUCTS LLC
17.3.4.1. Overview
17.3.4.2. Product Portfolio
17.3.4.3. Sales Footprint
17.3.4.4. Strategy Overview
17.3.5. B. BRAUN MELSUNGEN AG
17.3.5.1. Overview
17.3.5.2. Product Portfolio
17.3.5.3. Sales Footprint
17.3.5.4. Strategy Overview
17.3.6. JOHNSON & JOHNSON
17.3.6.1. Overview
17.3.6.2. Product Portfolio
17.3.6.3. Sales Footprint
17.3.6.4. Strategy Overview
17.3.7. KIMBERLY-CLARK CORPORATION
17.3.7.1. Overview
17.3.7.2. Product Portfolio
17.3.7.3. Sales Footprint
17.3.7.4. Strategy Overview
17.3.8. CARDINAL HEALTH
17.3.8.1. Overview
17.3.8.2. Product Portfolio
17.3.8.3. Sales Footprint
17.3.8.4. Strategy Overview
17.3.9. THE CLOROX COMPANY
17.3.9.1. Overview
17.3.9.2. Product Portfolio
17.3.9.3. Sales Footprint
17.3.9.4. Strategy Overview
17.3.10. SCHULKE & MAYR GMBH
17.3.10.1. Overview
17.3.10.2. Product Portfolio
17.3.10.3. Sales Footprint
17.3.10.4. Strategy Overview
18. Assumptions and Acronyms Used
19. Research Methodology
Explore Healthcare Insights
View Reports
Hospital Surgical Disinfectant Market
